Home » Reports » Broker Ratings » GlaxoSmithKline plc 4.1% Potential Decrease Indicated by Morgan Stanley

GlaxoSmithKline plc 4.1% Potential Decrease Indicated by Morgan Stanley

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Initiates/Starts’ with the recommendation being set at ‘UNDERWEIGHT’ this morning by analysts at Morgan Stanley. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Morgan Stanley have set a target price of 1520 GBX on its stock. This is indicating the analyst believes there is a potential downside of -4.1% from the opening price of 1585 GBX. Over the last 30 and 90 trading days the company share price has increased 33.6 points and increased 73 points respectively. The 52 week high for the stock is 1648.8 GBX while the year low share price is currently 1408.8 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,562.88 GBX and a 200 Day Moving Average share price is recorded at 1,541.53. There are currently 4,987,960,446 shares in issue with the average daily volume traded being 7,984,796. Market capitalisation for LON:GSK is £78,739,942,382 GBP.